Parallelism of Chemicostructural Properties between Filgrastim Originator and Three of Its Biosimilar Drugs

The approval and granting of marketing authorization for a putative biosimilar is based on strong comparability studies with its biological reference product. This is due to the complexity of the structure and nature of the manufacturing process of biological drugs. Hence, a rigorous analytical work...

Full description

Bibliographic Details
Main Authors: Alessandra Gianoncelli, Michela Bertuzzi, Michela Guarienti, Sara Vezzoli, Sara Anna Bonini, Andrea Mastinu, Sandra Sigala, Maurizio Memo
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Journal of Chemistry
Online Access:http://dx.doi.org/10.1155/2019/2751461